Early accessImproving daily
Back to directory
Anantys

Anantys

Freemium

French multi-asset portfolio tracker with automatic DSP2 bank sync and an AI copilot that scores your holdings out of 100.

Anantys is a French portfolio tracker that organises holdings into strategy-based portfolios — stock-picking, ETFs, dividends — across stocks, ETFs, funds, SCPI and cash, fed either by spreadsheet entry or automatic DSP2 read-only bank sync of PEA, CTO and assurance-vie accounts. Its differentiator is an always-on AI copilot that scores your portfolio's health out of 100 and explains momentum, correlation and diversification against your real positions, backed by proprietary metrics like Market Radar and a resilience ratio. A permanent free tier tracks up to €10,000 with bank sync included; paid tiers (€5.75–€20.75/month) lift the tracked-capital cap, portfolio count and monthly AI credits. It is deliberately a focused active-management tracker, not a whole-wealth aggregator — no crypto and no direct real estate.

Features at a glance

FeatureAnantys
PricingFreemium
Tracking & data
Manual entryYes
CSV / broker importYes
Automatic bank/broker syncYes
Multi-assetYes
Multi-currencyYes
Dividend trackingYes
Dividend/income forecastNot supported
Tax reportsNot supported
Analysis & insights
AI portfolio analysisYes
AI asset & market analysisPartial
Portfolio health scoreYes
Rebalancing & driftPartial
Goal & time-to-goalNot verified
Custom groupings / tagsNot supported
Return method (TWR/MWR)Not verified
Benchmark & alphaYes
Backtesting & scenariosNot verified
Access & pricing
Free tierYes
No account linking requiredYes
Open sourceNot supported
Self-hostableNot supported
Public APINot verified
Platform & reach
Mobile appPartial
Multi-languageYes
Community & extras
Public / social portfoliosNot verified
AI portfolio reviewNot supported
LegendSupportedPartial / limitedChecked — not availableNot verified yet

Best for

French and EU investors who want automatic PEA/CTO bank-sync tracking of stocks, ETFs, funds and SCPI with an AI health-score copilot and allocation-drift alerts, and who do not need crypto or a filing-ready tax report.

Strengths

  • Permanent free tier (up to €10k) that includes real DSP2 bank sync, not just a trial
  • Automatic read-only sync of PEA, CTO and assurance-vie via an approved aggregator, capturing dividends and corporate actions
  • AI copilot with a genuine 0–100 health score, correlation matrix and momentum metrics tuned to your holdings
  • Strategy portfolios plus target-allocation drift alerts — unusual depth for a consumer tracker
  • Bilingual French/English, EU-hosted and GDPR-compliant, with read-only sync

Trade-offs

  • No crypto and no direct real estate — not a whole-wealth aggregator
  • No dividend calendar/forecast and no filing-ready French tax report; export is CSV only
  • The return-calculation method (TWR/MWR/IRR) is undisclosed
  • No confirmed native mobile app yet — mobile web only; the iOS app is merely announced
  • Young, low-profile product with tracked-capital caps that push growing portfolios onto paid tiers

Anantys vs PortfolioGlance

Anantys is one of the closest matches to our thesis in France: an AI copilot that scores portfolio health out of 100, automatic PEA/CTO sync and drift alerts. The gaps are transparency and breadth — it does not disclose its return method, has no dividend forecast or tax report, and caps how much capital the free tier will track. PortfolioGlance discloses time- and money-weighted returns, adds rebalancing against a target and goal projection alongside its own health score and AI, and does not cap the value you can track for free. Pick Anantys if you want a French, PEA-native AI copilot; pick PortfolioGlance if you want a comparable health-and-AI experience with transparent returns and no capital cap.

Try PortfolioGlance free

Compare with

Verified 7/14/2026Sources: Anantys — Homepage (EN)Anantys — Pricing & PlansAnantys — Application de gestion de portefeuille (product article)Anantys vs Finary (crypto/real estate = no)Anantys — AI for managing your portfolio (health score /100)

This overview is editorial and for information only — not financial advice or an endorsement. Features and pricing may have changed since publication; check the official site for the latest details.